Bayer Pharmaceuticals accelerates innovations for patients
LifeProNow
MARCH 27, 2023
The estimated compounded annual growth rate is more than 26 percent reaching $1.36 billion in sales by 2026. Bayer works on leveraging all the possibilities of the technologies while fully integrating all regulatory and bioethical requirements.”
Let's personalize your content